Treace Medical Concepts Disappoints On Q3 Results, Lowers FY23 Guidance

Treace Medical Concepts Inc (NASDAQ:TMCI) shares are trading lower after the company reported worse-than-expected third-quarter financial results and lowered full-year 2023 revenue guidance below estimates.

What To Know: Treace Medical Concepts reported earnings losses of 28 cents per share which missed the analyst consensus estimate of losses of 26 cents, a 27.27% decrease over losses of 22 cents per share from the same period last year.